References
- Bista SR, Lobb M, Haywood A, et al. (2014). Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva. J Chromatogr B Analyt Technol Biomed Life Sci 960:27–33
- Bower S. (1981). Plasma protein binding of fentanyl. J Pharm Pharmacol 33:507–14
- Bowers WF, Fulton S, Thompson J. (1984). Ultrafiltration vs equilibrium dialysis for determination of free fraction. Clin Pharmacokinet 9:49–60
- Brash JL, Lyman DJ. (1969). Adsorption of plasma proteins in solution to uncharged, hydrophobic polymer surfaces. J Biomed Mater Res 3:175–89
- Goromaru T, Matsuura H, Yoshimura N, et al. (1984). Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography – mass spectrometry. Anesthesiology 61:73–7
- Guha Thakurta S, Subramanian A. (2011). Evaluation of in situ albumin binding surfaces: a study of protein adsorption and platelet adhesion. J Mater Sci Mater Med 22:137–49
- Kremer JM, Wilting J, Janssen LH. (1988). Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 40:1–47
- Kurz H, Trunk H, Weitz B. (1977). Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. Arzneimittelforschung 27:1373–80
- Maguire P, Tsai N, Kamal J, et al. (1992). Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors. Eur J Pharmacol 213:219–25
- Mather LE. (1983). Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8:422–46
- Meuldermans WE, Hurkmans RM, Heykants JJ. (1982). Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood. Arch Int Pharmacodyn Ther 257:4–19
- Miller RS, Peterson GM, Abbott F, et al. (1995). Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients. Br J Clin Pharmacol 40:553–6
- Pacifici GM, Viani A. (1992). Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clin Pharmacokinet 23:449–68
- Peters T. (1996). All about albumin: biochemistry, genetics, and medical applications. San Diego, CA: Academic Press
- Rothschild MA, Oratz M, Schreiber SS. (1988). Serum albumin. Hepatology 8:385–401
- Rowland M, Tozer TN. (2011). Clinical pharmacokinetics and pharmacodynamics: concepts and applications. Philadelphia, PA: Wolters Kluwer Health/Lippincott William & Wilkins
- Shargel L, Wu-Pong S, Yu ABC, et al. (2005). Applied biopharmaceutics & pharmacokinetics. New York: Appleton & Lange Reviews/McGraw-Hill, Medical Pub. Division
- Solassol I, Bressolle F, Caumette L, et al. (2005). Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients. Ther Drug Monit 27:491–8
- Streisand JB, Varvel JR, Stanski DR, et al. (1991). Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 75:223–9
- Taylor S, Harker A. (2006). Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids. J Pharma Biomed Anal 41:299–303
- Tesseromatis C, Alevizou A, Tigka E, et al. (2011). Acute-phase proteins: alpha-1-acid glycoprotein. In: Veas F, ed. Acute phase proteins – regulation and functions of acute phase proteins. Croatia, UK: In Tech. ISBN: 978-953-307-252-4
- Wang C, Williams NS. (2013). A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds. J Pharm Biomed Anal 75:112–17
- Wiesner G, Taeger K, Peter K. (1996). Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis. Anaesthesist 45:323–9
- Wilson AS, Stiller RL, Davis PJ, et al. (1997). Fentanyl and alfentanil plasma protein binding in preterm and term neonates. Anesth Analg 84:315–18
- Wright JD, Boudinot FD, Ujhelyi MR. (1996). Measurement and analysis of unbound drug concentrations. Clin Pharmacokinet 30:445–62